Phorbol ester-induced enhancement in lytic activity of CD8+ splenic T cells from low-dose melphalan-treated MOPC-315-tumor bearers. [electronic resource]
Producer: 19910426Description: 353-63 p. digitalISSN:- 0340-7004
- Animals
- Antigens, Differentiation, T-Lymphocyte -- physiology
- CD8 Antigens
- Cell Line
- Cytotoxicity, Immunologic -- drug effects
- Dose-Response Relationship, Drug
- Drug Synergism
- Female
- In Vitro Techniques
- Ionomycin -- pharmacology
- Lymphocyte Depletion
- Melphalan -- therapeutic use
- Mice
- Mice, Inbred BALB C
- Phagocytes -- physiology
- Plasmacytoma -- drug therapy
- T-Lymphocytes -- drug effects
- Tetradecanoylphorbol Acetate -- pharmacology
- Thymoma -- drug therapy
- Time Factors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.